| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffb1d04626beee0d53e30c4b89645af6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8db5efe4b1dca4aa3a08a45f01a9396e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85f6b45c065f4bcefc6ea4afec0b6b5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c75412d6bf7a7c35b91a6f21a598f87 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
| filingDate |
2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4461e6e00dbc33d9a69b4420eeee7955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c84858bab7b856ecbe044c304f756f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88f27d06ace1ac5fbc7c1e330e943c51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bcfe0a5dc724a7d1ed0fc6e615013cd |
| publicationDate |
2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012166654-A1 |
| titleOfInvention |
Cyanoquinoline compounds having activity in correcting mutant-cftr processing and increasing ion transport and uses thereof |
| abstract |
The present disclosure provides pharmaceutical compositions, pharmaceutical preparations and methods for increasing activity of a mutant cystic fibrosis transmembrane conductance regulator protein (mutant-CFTR). The pharmaceutical compositions, pharmaceutical preparations and methods are useful for the study and treatment of disorders associated with mutant-CFTR, such as cystic fibrosis. The pharmaceutical compositions and pharmaceutical preparations may include one or more cyanoquinoline-containing compounds of the embodiments, or an analog or derivative thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020049189-A1 |
| priorityDate |
2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |